Company Overview and News

0
Sterlite Technologies down 5% despite better Q1 numbers

13h moneycontrol
Shares of Sterlite Technologies fell 5.5 percent intraday Thursday despite better numbers declared by the company in the quarter ended June 2018.
SRLRY 532374 STRTECH

0
Sterlite Technologies Limited - Financial Result Updates

15h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

0
Kotak Bank, Bajaj Finserv, ABB results

2018-07-18 thehindubusinessline
Thursday will see a host of most actively tracked companies declaring their results for the period ended June 2018. Among these are 21st Century, AB Money, ABB, Bajaj Finserv, Bajaj Finance, Bharat Immunologicals, DB Corp, GNA Axles, Hatsun Agro, Integra Engineering, Kotak Mahindra Bank, Omax Autos, RBL Bank, Shree Digvijay Cement, Sterlite Technologies, Sagar Cements, South India Paper, Suraj, VLS Finance, Valecha Engineering and Vikas EcoTech.
VALECHAENG SAGCEM OMAXAUTO KMBKY SHREDIGCEM 532978 502090 STRTECH 511333 530961 VIKASECO 532389 SRLRY BAJAJFINSV 502180 BAJFINANCE 532374 KOTAKBANK BJJQY 520021 500247 VLSFINANCE 500034

0
Sterlite Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

0
Sterlite Technologies: European acquisition would be value accretive

2018-07-12 moneycontrol
Sterlite Technologies is riding the upturn in global optical cable demand and looking at growth through the organic as well as inorganic route. It recently acquired complete stake in European Metallurgica Bresciana (MB), which specialises in optical cables. The acquisition will help in two critical ways:
SRLRY 532374 STRTECH

0
An evening walk down Dalal Street: Global cues lift Sensex 277 pts ahead of Q1FY19 earnings

2018-07-09 moneycontrol
Equity benchmarks began the week on a strong note on Monday, gaining over 0.70 percent on positive global cues and ahead of June quarter earnings. Banks and metals stocks, and Reliance Industries, L&T and Infosys drove the market higher.
DB 500325 500820 JIPKY RELIANCE KTKBANK 532538 ASIANPAINT 532187 505283 RIGD UCLQY 500493 BHARATFORG RLNIY YESBANK INDUSINDBK KIRLPNU JPASSOCIAT UCLQF 532648 YYBKY STRTECH ULTRACEMCO 532532 SRLRY 532652 532374

0
Movers Shakers: Volumes of Garnet International Ramco Cements rose up to 37,000%

2018-07-09 moneycontrol
The market is trading on a positive note this Monday afternoon with the Nifty up 84 points at 10,857 and the Sensex gaining 287 points at 35,945.
526849 SRLRY 534976 VMART 500260 532374 512493 RMCTY RAMCOCEM GARNETINT STRTECH BANARBEADS

0
Sterlite Technologies up 6% as Co to acquire 100% in European optical fiber cable manufacturer

2018-07-09 moneycontrol
Share price of Sterlite Technologies rose 6.4 percent intraday Monday as company to acquire European specialized optical cable manufacturer based in Italy.
SRLRY 532374 STRTECH

0
Sterlite Technologies hits 1-month high

2018-07-09 thehindubusinessline
Shares of optical fibre cable maker Sterlite Technologies Ltd climbed as much as 6.58 per cent to Rs 308.6, highest since June 13, as the company’s unit has agreed to buy Italy's Metallurgica Bresciana for about €47 million.
SRLRY 532374 STRTECH

0
Ajanta Pharma still in a downtrend

2018-07-08 premium.thehindubusinessline
Can I buy Ajanta Pharma at these levels? When should I exit? Can this be considered a buy for the long term?
SRLRY 532331 532374 AJANTPHARM STRTECH

0
Sterlite Tech to Acquire European Specialised Optical Cable Manufacturer to Expand Global Presence

2018-07-07 moneycontrol
Sterlite Tech, through its wholly owned Italian subsidiary Sterlite Technologies S.p.A, will acquire 100% stake in Metallurgica Bresciana S.p.A (Metallurgica).
SRLRY 532374 STRTECH

0
Sterlite Tech: Europe acquisition bodes well

2018-07-06 thehindubusinessline
Sterlite Technologies on Friday said that one of its subsidiaries will acquire Metallurgica Bresciana, a European specialised optical cable manufacturer, for €47 million in an all-cash deal.
SRLRY 532374 STRTECH

0
Sterlite Tech#39;s Italian unit to buy Metallurgica Bresciana for 47 million euros

2018-07-06 moneycontrol
Sterlite Technologies today said one of its subsidiaries will acquire Metallurgica Bresciana, a European specialised optical cable manufacturer, for 47 million euros in an all-cash deal.
SRLRY 532374 STRTECH

0
Sterlite Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SRLRY 532374 STRTECH

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...